Eswar R. Krishnan

Internal Medicine

300 Pasteur Dr
Stanford, CA 94305

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Persistence of surrogates for high consequence viral and bacterial pathogens in a pilot-scale activated sludge treatment system.

Persistence of surrogates for high consequence viral and bacterial pathogens in a pilot-scale activated sludge treatment system.

Journal: PloS one

Published: April 07, 2022

Effectiveness of point-of-use/point-of-entry systems to remove per- and polyfluoroalkyl substances from drinking water.

Effectiveness of point-of-use/point-of-entry systems to remove per- and polyfluoroalkyl substances from drinking water.

Journal: AWWA water science

Published: July 25, 2019

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.

Journal: Annals of the rheumatic diseases

Published: March 14, 2019

Evaluation of an environmentally sustainable UV-assisted water treatment system for the removal of Bacillus globigii spores in water.

Evaluation of an environmentally sustainable UV-assisted water treatment system for the removal of Bacillus globigii spores in water.

Journal: Water science & technology, water supply

Published: December 04, 2018

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.

An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: August 31, 2018

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: August 21, 2018

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.

Journal: Lancet (London, England)

Published: July 07, 2018

Inactivation of Bacillus Spores in Wash Waters Using Dilute Chlorine Bleach Solutions at Different Temperatures and pH Levels.

Inactivation of Bacillus Spores in Wash Waters Using Dilute Chlorine Bleach Solutions at Different Temperatures and pH Levels.

Journal: Water environment research : a research publication of the Water Environment Federation

Published: June 25, 2017

Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS(®) Physical Function.

Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS(®) Physical Function.

Journal: Journal of general internal medicine

Published: May 21, 2015

Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study.

Chronic kidney disease as a risk factor for incident gout among men and women: retrospective cohort study using data from the Framingham Heart Study.

Journal: BMJ open

Published: April 15, 2015

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging.

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging.

Journal: PloS one

Published: April 02, 2015

Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria.

Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria.

Journal: Scandinavian journal of rheumatology

Published: March 07, 2015

Showing 1-12 of 57

Last Updated: 09/26/2026